User login
Innovation in colorectal cancer screening
Disregard what is currently accepted as state of the art, reimagine the present as an imperfect stepping stone, and envision a future in which colorectal cancer (CRC) screening and surveillance are optimized. This was the direction for attendees of AGA’s consensus conference — Colorectal Cancer Screening and Surveillance: Role of Emerging Technology and Innovation to Improve Outcomes.
The AGA Center for GI Innovation and Technology invited leading academic and industry experts to a working meeting to identify barriers to the optimization of CRC screening and surveillance, and to define a roadmap for overcoming these barriers.
Meeting conclusions
Although colonoscopy is widely considered to be an excellent tool for CRC screening and surveillance, barriers to optimal effectiveness exist. Barriers include lack of access to health care, financial cost, suboptimal uptake even among individuals with health insurance and financial resources, imperfect adherence to guidelines, and development of early-age, and interval cancers despite adherence to guidelines.
Novel cost-effective, sensitive, specific, and personalized strategies are needed to address these barriers.
To read about the emerging technologies discussed at the meeting, review the meeting summary in Gastroenterology.
ginews@gastro.org
Disregard what is currently accepted as state of the art, reimagine the present as an imperfect stepping stone, and envision a future in which colorectal cancer (CRC) screening and surveillance are optimized. This was the direction for attendees of AGA’s consensus conference — Colorectal Cancer Screening and Surveillance: Role of Emerging Technology and Innovation to Improve Outcomes.
The AGA Center for GI Innovation and Technology invited leading academic and industry experts to a working meeting to identify barriers to the optimization of CRC screening and surveillance, and to define a roadmap for overcoming these barriers.
Meeting conclusions
Although colonoscopy is widely considered to be an excellent tool for CRC screening and surveillance, barriers to optimal effectiveness exist. Barriers include lack of access to health care, financial cost, suboptimal uptake even among individuals with health insurance and financial resources, imperfect adherence to guidelines, and development of early-age, and interval cancers despite adherence to guidelines.
Novel cost-effective, sensitive, specific, and personalized strategies are needed to address these barriers.
To read about the emerging technologies discussed at the meeting, review the meeting summary in Gastroenterology.
ginews@gastro.org
Disregard what is currently accepted as state of the art, reimagine the present as an imperfect stepping stone, and envision a future in which colorectal cancer (CRC) screening and surveillance are optimized. This was the direction for attendees of AGA’s consensus conference — Colorectal Cancer Screening and Surveillance: Role of Emerging Technology and Innovation to Improve Outcomes.
The AGA Center for GI Innovation and Technology invited leading academic and industry experts to a working meeting to identify barriers to the optimization of CRC screening and surveillance, and to define a roadmap for overcoming these barriers.
Meeting conclusions
Although colonoscopy is widely considered to be an excellent tool for CRC screening and surveillance, barriers to optimal effectiveness exist. Barriers include lack of access to health care, financial cost, suboptimal uptake even among individuals with health insurance and financial resources, imperfect adherence to guidelines, and development of early-age, and interval cancers despite adherence to guidelines.
Novel cost-effective, sensitive, specific, and personalized strategies are needed to address these barriers.
To read about the emerging technologies discussed at the meeting, review the meeting summary in Gastroenterology.
ginews@gastro.org
Top AGA Community patient cases
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community (https://community.gastro.org) to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses.
Here are some recent clinical discussions in the forum regarding the coronavirus and your patients:
1. Biologic treatment for IBD in the COVID-19 era (http://ow.ly/9akD50yKW8E)
A GI colleague from Italy asks how others are managing IBD patients on ongoing biologic treatment during the coronavirus pandemic.
2. COVID-19 and colonoscopy (http://ow.ly/uYUD50yKWfS)
AGA members discuss recommendations for infection control in endoscopy centers.
3. IBD patients concerned about visiting infusion centers (http://ow.ly/gKED50yKWVZ)
How would you address patient concerns about picking up coronavirus from asymptomatic carriers at bustling infusion centers?
Join these discussions and more at https://community.gastro.org/discussions.
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community (https://community.gastro.org) to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses.
Here are some recent clinical discussions in the forum regarding the coronavirus and your patients:
1. Biologic treatment for IBD in the COVID-19 era (http://ow.ly/9akD50yKW8E)
A GI colleague from Italy asks how others are managing IBD patients on ongoing biologic treatment during the coronavirus pandemic.
2. COVID-19 and colonoscopy (http://ow.ly/uYUD50yKWfS)
AGA members discuss recommendations for infection control in endoscopy centers.
3. IBD patients concerned about visiting infusion centers (http://ow.ly/gKED50yKWVZ)
How would you address patient concerns about picking up coronavirus from asymptomatic carriers at bustling infusion centers?
Join these discussions and more at https://community.gastro.org/discussions.
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community (https://community.gastro.org) to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses.
Here are some recent clinical discussions in the forum regarding the coronavirus and your patients:
1. Biologic treatment for IBD in the COVID-19 era (http://ow.ly/9akD50yKW8E)
A GI colleague from Italy asks how others are managing IBD patients on ongoing biologic treatment during the coronavirus pandemic.
2. COVID-19 and colonoscopy (http://ow.ly/uYUD50yKWfS)
AGA members discuss recommendations for infection control in endoscopy centers.
3. IBD patients concerned about visiting infusion centers (http://ow.ly/gKED50yKWVZ)
How would you address patient concerns about picking up coronavirus from asymptomatic carriers at bustling infusion centers?
Join these discussions and more at https://community.gastro.org/discussions.
AGA app improves your patient’s health and bottom line
AGA has partnered with Rx.Health, a digital health company, to create a colorectal cancer (CRC) preparatory app.
You want to find ways to improve your patient outcomes and reduce your practice costs? Now, there is an app for that. The CRC preparatory app can reduce expenses you lose from aborted or incomplete colonoscopies.
Launched in 2019, the CRC app is already generating remarkable results. The Arizona Center for Digestive Health used the CRC app and recorded a 24% improvement in bowel preparation by colonoscopy patients, a 50% reduction in aborted procedures and a 93% patient satisfaction rate. Research conducted by Rx.Health also determined patients were using the CRC app two to four times longer than competing apps, and the CRC app was saving gastroenterologists between $20,000 and $40,000 annually.
Plans are underway between AGA and Rx.Health to expand the partnership to build apps for colorectal cancer surveillance, an inflammatory bowel disease (IBD) registry, fecal microbiota transplantation (FMT), and other GI disorders.
Interested in learning more? Visit rx.health/gi.
AGA has partnered with Rx.Health, a digital health company, to create a colorectal cancer (CRC) preparatory app.
You want to find ways to improve your patient outcomes and reduce your practice costs? Now, there is an app for that. The CRC preparatory app can reduce expenses you lose from aborted or incomplete colonoscopies.
Launched in 2019, the CRC app is already generating remarkable results. The Arizona Center for Digestive Health used the CRC app and recorded a 24% improvement in bowel preparation by colonoscopy patients, a 50% reduction in aborted procedures and a 93% patient satisfaction rate. Research conducted by Rx.Health also determined patients were using the CRC app two to four times longer than competing apps, and the CRC app was saving gastroenterologists between $20,000 and $40,000 annually.
Plans are underway between AGA and Rx.Health to expand the partnership to build apps for colorectal cancer surveillance, an inflammatory bowel disease (IBD) registry, fecal microbiota transplantation (FMT), and other GI disorders.
Interested in learning more? Visit rx.health/gi.
AGA has partnered with Rx.Health, a digital health company, to create a colorectal cancer (CRC) preparatory app.
You want to find ways to improve your patient outcomes and reduce your practice costs? Now, there is an app for that. The CRC preparatory app can reduce expenses you lose from aborted or incomplete colonoscopies.
Launched in 2019, the CRC app is already generating remarkable results. The Arizona Center for Digestive Health used the CRC app and recorded a 24% improvement in bowel preparation by colonoscopy patients, a 50% reduction in aborted procedures and a 93% patient satisfaction rate. Research conducted by Rx.Health also determined patients were using the CRC app two to four times longer than competing apps, and the CRC app was saving gastroenterologists between $20,000 and $40,000 annually.
Plans are underway between AGA and Rx.Health to expand the partnership to build apps for colorectal cancer surveillance, an inflammatory bowel disease (IBD) registry, fecal microbiota transplantation (FMT), and other GI disorders.
Interested in learning more? Visit rx.health/gi.
Announcing AGA’s new endoscopy journal
The recent explosion of innovations for the diagnosis and treatment of GI diseases makes it difficult to identify what will affect you today and what has implications for tomorrow.
Techniques and Innovations in Gastrointestinal Endoscopy (TIGE) cuts through the noise with quarterly updates featuring groundbreaking advances in GI endoscopy. Previously known as Techniques in Gastrointestinal Endoscopy, TIGE is the newest member of the AGA journal family and illuminates the next generation of technologies in an easily accessible, online-only format. TIGE will continue to be led by Co-Editors-in-Chief Vinay Chandrasekhara, MD, Mayo Clinic, Rochester, Minn., and Michael Kochman, MD, AGAF, University of Pennsylvania School of Medicine, Philadelphia, and a hand-selected editorial board of leaders in GI endoscopy.
Check out the current issue of TIGE focused on how lumen apposing metal stents (LAMS) are changing GI endoscopy. The issue provides a comprehensive review on the current state of LAMS and best practices for using LAMS to optimize patient outcomes.
Discover TIGE at tigejournal.org.
ginews@gastro.org
The recent explosion of innovations for the diagnosis and treatment of GI diseases makes it difficult to identify what will affect you today and what has implications for tomorrow.
Techniques and Innovations in Gastrointestinal Endoscopy (TIGE) cuts through the noise with quarterly updates featuring groundbreaking advances in GI endoscopy. Previously known as Techniques in Gastrointestinal Endoscopy, TIGE is the newest member of the AGA journal family and illuminates the next generation of technologies in an easily accessible, online-only format. TIGE will continue to be led by Co-Editors-in-Chief Vinay Chandrasekhara, MD, Mayo Clinic, Rochester, Minn., and Michael Kochman, MD, AGAF, University of Pennsylvania School of Medicine, Philadelphia, and a hand-selected editorial board of leaders in GI endoscopy.
Check out the current issue of TIGE focused on how lumen apposing metal stents (LAMS) are changing GI endoscopy. The issue provides a comprehensive review on the current state of LAMS and best practices for using LAMS to optimize patient outcomes.
Discover TIGE at tigejournal.org.
ginews@gastro.org
The recent explosion of innovations for the diagnosis and treatment of GI diseases makes it difficult to identify what will affect you today and what has implications for tomorrow.
Techniques and Innovations in Gastrointestinal Endoscopy (TIGE) cuts through the noise with quarterly updates featuring groundbreaking advances in GI endoscopy. Previously known as Techniques in Gastrointestinal Endoscopy, TIGE is the newest member of the AGA journal family and illuminates the next generation of technologies in an easily accessible, online-only format. TIGE will continue to be led by Co-Editors-in-Chief Vinay Chandrasekhara, MD, Mayo Clinic, Rochester, Minn., and Michael Kochman, MD, AGAF, University of Pennsylvania School of Medicine, Philadelphia, and a hand-selected editorial board of leaders in GI endoscopy.
Check out the current issue of TIGE focused on how lumen apposing metal stents (LAMS) are changing GI endoscopy. The issue provides a comprehensive review on the current state of LAMS and best practices for using LAMS to optimize patient outcomes.
Discover TIGE at tigejournal.org.
ginews@gastro.org
COVID-19 message from AGA
The AGA Governing Board recognizes and shares the extreme uncertainty faced by the GI community regarding the rapidly evolving coronavirus situation. Priority #1 is, as always, keeping our patients and families safe, but we also would like to ensure the safety of our GI health care providers.
COVID-19 is an emerging disease and there is more to learn about its transmission, severity, and how it will take shape in the U.S. We have asked our clinical guidance experts to determine what, if any, GI-specific scientifically valid recommendations can be made. In fact, Gastroenterology has just published papers on GI symptoms and potential fecal transmission in coronavirus patients. You can see this work at www.gastrojournal.org/inpress.
Stay tuned to www.gastro.org and your email for continued updates on coronavirus, as well as information on AGA live events and DDW given the current circumstances.
The AGA Governing Board recognizes and shares the extreme uncertainty faced by the GI community regarding the rapidly evolving coronavirus situation. Priority #1 is, as always, keeping our patients and families safe, but we also would like to ensure the safety of our GI health care providers.
COVID-19 is an emerging disease and there is more to learn about its transmission, severity, and how it will take shape in the U.S. We have asked our clinical guidance experts to determine what, if any, GI-specific scientifically valid recommendations can be made. In fact, Gastroenterology has just published papers on GI symptoms and potential fecal transmission in coronavirus patients. You can see this work at www.gastrojournal.org/inpress.
Stay tuned to www.gastro.org and your email for continued updates on coronavirus, as well as information on AGA live events and DDW given the current circumstances.
The AGA Governing Board recognizes and shares the extreme uncertainty faced by the GI community regarding the rapidly evolving coronavirus situation. Priority #1 is, as always, keeping our patients and families safe, but we also would like to ensure the safety of our GI health care providers.
COVID-19 is an emerging disease and there is more to learn about its transmission, severity, and how it will take shape in the U.S. We have asked our clinical guidance experts to determine what, if any, GI-specific scientifically valid recommendations can be made. In fact, Gastroenterology has just published papers on GI symptoms and potential fecal transmission in coronavirus patients. You can see this work at www.gastrojournal.org/inpress.
Stay tuned to www.gastro.org and your email for continued updates on coronavirus, as well as information on AGA live events and DDW given the current circumstances.
Help honor today’s luminaries in GI
The AGA Research Foundation is dedicated to supporting future leaders in GI while highlighting today’s luminaries.
Our new program, AGA Honors: Celebrating Difference Makers in Our Field, recognizes individuals who have played a pivotal role in shaping the fields of gastroenterology and hepatology and raises funds for the next generation of investigators working to advance digestive disease research and patient care.
Learn more about our honorees by visiting our website at http://foundation.gastro.org/aga-honors-celebrating/. Help us celebrate their achievements by donating to the AGA Research Foundation. Contributions are tax-deductible and will go directly to the Foundation research award endowment.
The AGA Research Foundation is dedicated to supporting future leaders in GI while highlighting today’s luminaries.
Our new program, AGA Honors: Celebrating Difference Makers in Our Field, recognizes individuals who have played a pivotal role in shaping the fields of gastroenterology and hepatology and raises funds for the next generation of investigators working to advance digestive disease research and patient care.
Learn more about our honorees by visiting our website at http://foundation.gastro.org/aga-honors-celebrating/. Help us celebrate their achievements by donating to the AGA Research Foundation. Contributions are tax-deductible and will go directly to the Foundation research award endowment.
The AGA Research Foundation is dedicated to supporting future leaders in GI while highlighting today’s luminaries.
Our new program, AGA Honors: Celebrating Difference Makers in Our Field, recognizes individuals who have played a pivotal role in shaping the fields of gastroenterology and hepatology and raises funds for the next generation of investigators working to advance digestive disease research and patient care.
Learn more about our honorees by visiting our website at http://foundation.gastro.org/aga-honors-celebrating/. Help us celebrate their achievements by donating to the AGA Research Foundation. Contributions are tax-deductible and will go directly to the Foundation research award endowment.
Top AGA Community patient cases
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community (https://community.gastro.org) to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses. In case you missed it, here are the most popular clinical discussions shared in the forum recently:
1. Adherence to noninvasive CRC screening (http://ow.ly/6eng30qfUKq)
2. Q&A with Guideline authors: Management of gastric intestinal metaplasia (GIM) (http://ow.ly/Cxsl30qfUYm).
3. IBD patient: Crohn’s colitis (http://ow.ly/DsOg30qfUNt).
4. Patient with intractable abdominal pain (http://ow.ly/EPFi30qfUsi).
5. IBD patient: Ulcerative colitis (http://ow.ly/d6e730qfUVZ).
Access these clinical cases and more discussions at https://community.gastro.org/discussions.
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community (https://community.gastro.org) to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses. In case you missed it, here are the most popular clinical discussions shared in the forum recently:
1. Adherence to noninvasive CRC screening (http://ow.ly/6eng30qfUKq)
2. Q&A with Guideline authors: Management of gastric intestinal metaplasia (GIM) (http://ow.ly/Cxsl30qfUYm).
3. IBD patient: Crohn’s colitis (http://ow.ly/DsOg30qfUNt).
4. Patient with intractable abdominal pain (http://ow.ly/EPFi30qfUsi).
5. IBD patient: Ulcerative colitis (http://ow.ly/d6e730qfUVZ).
Access these clinical cases and more discussions at https://community.gastro.org/discussions.
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community (https://community.gastro.org) to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses. In case you missed it, here are the most popular clinical discussions shared in the forum recently:
1. Adherence to noninvasive CRC screening (http://ow.ly/6eng30qfUKq)
2. Q&A with Guideline authors: Management of gastric intestinal metaplasia (GIM) (http://ow.ly/Cxsl30qfUYm).
3. IBD patient: Crohn’s colitis (http://ow.ly/DsOg30qfUNt).
4. Patient with intractable abdominal pain (http://ow.ly/EPFi30qfUsi).
5. IBD patient: Ulcerative colitis (http://ow.ly/d6e730qfUVZ).
Access these clinical cases and more discussions at https://community.gastro.org/discussions.
GI leaders receive AGA’s prestigious recognition prizes
AGA has announced the 2020 recipients of the annual recognition prizes, given in honor of outstanding contributions and achievements in gastroenterology.
“AGA Recognition Prizes allow members to honor their colleagues and peers for outstanding contributions to the field of gastroenterology,” said Hashem B. El-Serag, MD, MPH, AGAF, president of the AGA Institute. “The 2020 AGA Recognition Prize winners are just a few of the distinguished and talented members who help make AGA such an accomplished organization. We are honored that such esteemed individuals are representatives of AGA.”
The AGA Recognition Prizes will be presented during Digestive Disease Week® 2020, May 1-5, 2020, in Chicago, Illinois.
Julius Friedenwald Medal
AGA bequeaths its highest honor, the Julius Friedenwald Medal, to Gail Hecht, MD, MS, AGAF, for her substantial contributions to the field of gastroenterology and AGA. The Julius Friedenwald Medal, presented annually since 1941, recognizes a physician for lifelong contributions to the field of gastroenterology.
Dr. Hecht is internationally renowned for her pivotal contributions to the understanding of the important diarrheal pathogen, enteropathogenic E. coli. She is also a passionate advocate for the science and practice of gastroenterology, including serving as AGA Institute President. Dr. Hecht’s collegial and generous spirit, her past and continued leadership roles in AGA, her passion for and contributions to science and clinical medicine, and her dedication to both her patients and trainees have strengthened the specialty of gastroenterology, and also inspired and shaped the next generation of investigators and gastroenterologists. Dr. Hecht is currently assistant dean, medical student research and professor of medicine and microbiology/immunology at Loyola University Chicago Stritch School of Medicine, and a staff physician at Hines VA Medical Center, Chicago, Ill.
Distinguished Achievement Award in Basic Science
AGA recognizes R. Balfour Sartor, MD, with the AGA Distinguished Achievement Award in Basic Science, for his major accomplishments in basic science research, which have significantly contributed to the understanding of the pathogenesis of inflammatory bowel diseases (IBD). Dr. Sartor’s seminal observations throughout his career helped launch the area of inquiry that led to the recognition that the microbiome is a key to metabolic disease, IBD, intestinal neoplasia and hepatic disorders. Dr. Sartor is the Margaret W. and Lorimer W. Midgett Distinguished Professor and a professor, departments of medicine, microbiology and immunology, University of North Carolina, Chapel Hill.
William Beaumont Prize
AGA honors two individuals with the William Beaumont Prize in Gastroenterology, which recognizes individuals who have made unique, outstanding contributions of major importance to the field of gastroenterology.
Dennis Ahnen, MD, AGAF, had made many contributions to the field of gastroenterology that have significantly advanced the care of patients through clinical and translational research into the pathobiology of colorectal cancer and its prevention. Dr. Ahnen, has provided exemplary service to AGA. He is director of genetics at Gastroenterology of the Rockies and Professor Emeritus of medicine at the University of Colorado Anschutz Medical Campus School of Medicine, Aurora.
Peter Kahrilas, MD, AGAF, has worked tirelessly and creatively to characterize the function and pathophysiology of the esophagus and has written the esophageal papers upon which a large portion of current research is based. Dr. Kahrilas has also dedicated many years of service to AGA and is currently the Gilbert H. Marquardt Professor of Medicine in the division of gastroenterology at the Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Distinguished Educator Award
AGA honors Robert Fontana, MD, with the Distinguished Educator Award, which recognizes an individual who has made outstanding contributions as an educator in gastroenterology on both local and national levels. Dr. Fontana’s greatest teaching impact has been the establishment of one of the most highly successful transplant hepatology fellowship training programs in the country. He has taught countless medical students, residents and fellows, as well as faculty members via his clear, concise, and well-organized lectures and presentations. Dr. Fontana is a professor of medicine, medical director of liver transplantation, and director of transplant hepatology fellowship ACGME-accredited training program at the University of Michigan, Ann Arbor.
Distinguished Clinician Awards
The AGA Distinguished Clinician Awards recognize members of the practicing community who, by example, combine the art of medicine with the skills demanded by the scientific body of knowledge in service to their patients.
AGA presents the Distinguished Clinician Award in Private Practice to Kimberly Persley, MD, AGAF. Dr. Persley made a huge impact on patient care in her community as the first IBD-specialty trained private practice gastroenterologist in the Dallas-Fort Worth, Texas, region. She was sought out by gastroenterologists and patients throughout the region for her thorough, kind and holistic care. Dr. Persley is a partner at Texas Digestive Disease Consultants and assistant clinical professor of medicine at the University of Texas Southwestern Medical School, Dallas, Texas.
AGA is honored to present the Distinguished Clinician Award in Clinical Academic Practice, to Gary Lichtenstein, MD, AGAF. Dr. Lichtenstein is a renowned physician, educator, and investigator whose local, regional, and national prominence is remarkable. Patients and physicians throughout the country seek his consultation and advice in IBD. Dr. Lichtenstein is a professor of medicine and director of the IBD Center at the University of Pennsylvania, Philadelphia.
Distinguished Mentor Award
AGA bestows the Distinguished Mentor Award to Juanita Merchant, MD, PhD. This award recognizes an individual who has made a lifelong effort dedicated to the mentoring of trainees in the field of gastroenterology and for achievements as outstanding mentors throughout their careers. Dr. Merchant is an exceptional mentor, providing guidance to multiple learners to jump start, enhance and guide their careers as scientists in gastroenterology. Many of her trainees are faculty in institutions around the world who have also stimulated young learners to pursue careers in science. Dr. Merchant is professor and chief of gastroenterology and hepatology at the University of Arizona, Tucson.
Research Service Award
AGA honors Peter Perrin, PhD, with the Research Service Award, which recognizes individuals whose work has significantly advanced gastroenterological science and research. As a program director at the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, Dr. Perrin has had a huge impact on NIH-funded digestive diseases research. At NIDDK, he has the largest portfolio of grants that have high impact in digestive diseases, in topics including immunology, microbiology, infectious diseases and IBD, barrier and transport functions, and AIDS/HIV.
Outstanding Service Award
AGA honors the Funderburg family with the Outstanding Service Award, which was created in 1972 to honor an individual(s) who has contributed significantly to society’s health and welfare. The family, which includes Rob and Cathy, Alex and Patty, and Hugh and Gail, has significantly contributed to the AGA Research Foundation through their personal philanthropy. Their parents established the AGA – R. Robert and Sally Funderburg Research Award in Gastric Cancer in 1992. In total, the family has given $3 million and with their most recent gift, they have permanently endowed their research award in gastric cancer.
The family encourages collaboration and communication between and among the Funderburg recipients and as a result, AGA established the annual Funderburg Symposium at DDW. This symposium allows leaders in the gastric cancer field, many of whom are past Funderburg recipients, to come together and learn about the latest advances and findings in gastric cancer research.
Young Investigator Awards
The AGA Young Investigator Awards recognize two young investigators, one in basic science and one in clinical science, for outstanding research achievements.
AGA honors Jennifer Lai, MD, MBA, with the Young Investigator Award in Clinical Science. Dr. Lai has pioneered a research program in frailty in hepatology that is changing the way that gastroenterologists and hepatologists manage patients with liver disease. She has carved out a niche at the junction of aging and hepatology research that is particularly timely given the influx of older patients with cirrhosis being seen in clinical practice, as well as the rapid rise in cirrhotic patients with multiple co-morbidities and frailty seeking liver transplantation. Dr. Lai is an associate professor of medicine in residence and director of the Advancing Research in Clinical Hepatology Group in the division of gastroenterology and hepatology, at the University of California, San Francisco.
AGA honors Nobuhiko Kamada, PhD, with the Young Investigator Award in Basic Science. Dr. Kamada is known for his innovation combining fields examining the microbiota and the immune system in IBD, specifically, the interplay between diet, commensal and pathogenic microbes, and the immune system. He has published stellar findings that have been highly cited within short periods of time due to their innovation. Dr. Kamada is an assistant professor in the division of gastroenterology at the University of Michigan Medical School, Ann Arbor.
AGA has announced the 2020 recipients of the annual recognition prizes, given in honor of outstanding contributions and achievements in gastroenterology.
“AGA Recognition Prizes allow members to honor their colleagues and peers for outstanding contributions to the field of gastroenterology,” said Hashem B. El-Serag, MD, MPH, AGAF, president of the AGA Institute. “The 2020 AGA Recognition Prize winners are just a few of the distinguished and talented members who help make AGA such an accomplished organization. We are honored that such esteemed individuals are representatives of AGA.”
The AGA Recognition Prizes will be presented during Digestive Disease Week® 2020, May 1-5, 2020, in Chicago, Illinois.
Julius Friedenwald Medal
AGA bequeaths its highest honor, the Julius Friedenwald Medal, to Gail Hecht, MD, MS, AGAF, for her substantial contributions to the field of gastroenterology and AGA. The Julius Friedenwald Medal, presented annually since 1941, recognizes a physician for lifelong contributions to the field of gastroenterology.
Dr. Hecht is internationally renowned for her pivotal contributions to the understanding of the important diarrheal pathogen, enteropathogenic E. coli. She is also a passionate advocate for the science and practice of gastroenterology, including serving as AGA Institute President. Dr. Hecht’s collegial and generous spirit, her past and continued leadership roles in AGA, her passion for and contributions to science and clinical medicine, and her dedication to both her patients and trainees have strengthened the specialty of gastroenterology, and also inspired and shaped the next generation of investigators and gastroenterologists. Dr. Hecht is currently assistant dean, medical student research and professor of medicine and microbiology/immunology at Loyola University Chicago Stritch School of Medicine, and a staff physician at Hines VA Medical Center, Chicago, Ill.
Distinguished Achievement Award in Basic Science
AGA recognizes R. Balfour Sartor, MD, with the AGA Distinguished Achievement Award in Basic Science, for his major accomplishments in basic science research, which have significantly contributed to the understanding of the pathogenesis of inflammatory bowel diseases (IBD). Dr. Sartor’s seminal observations throughout his career helped launch the area of inquiry that led to the recognition that the microbiome is a key to metabolic disease, IBD, intestinal neoplasia and hepatic disorders. Dr. Sartor is the Margaret W. and Lorimer W. Midgett Distinguished Professor and a professor, departments of medicine, microbiology and immunology, University of North Carolina, Chapel Hill.
William Beaumont Prize
AGA honors two individuals with the William Beaumont Prize in Gastroenterology, which recognizes individuals who have made unique, outstanding contributions of major importance to the field of gastroenterology.
Dennis Ahnen, MD, AGAF, had made many contributions to the field of gastroenterology that have significantly advanced the care of patients through clinical and translational research into the pathobiology of colorectal cancer and its prevention. Dr. Ahnen, has provided exemplary service to AGA. He is director of genetics at Gastroenterology of the Rockies and Professor Emeritus of medicine at the University of Colorado Anschutz Medical Campus School of Medicine, Aurora.
Peter Kahrilas, MD, AGAF, has worked tirelessly and creatively to characterize the function and pathophysiology of the esophagus and has written the esophageal papers upon which a large portion of current research is based. Dr. Kahrilas has also dedicated many years of service to AGA and is currently the Gilbert H. Marquardt Professor of Medicine in the division of gastroenterology at the Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Distinguished Educator Award
AGA honors Robert Fontana, MD, with the Distinguished Educator Award, which recognizes an individual who has made outstanding contributions as an educator in gastroenterology on both local and national levels. Dr. Fontana’s greatest teaching impact has been the establishment of one of the most highly successful transplant hepatology fellowship training programs in the country. He has taught countless medical students, residents and fellows, as well as faculty members via his clear, concise, and well-organized lectures and presentations. Dr. Fontana is a professor of medicine, medical director of liver transplantation, and director of transplant hepatology fellowship ACGME-accredited training program at the University of Michigan, Ann Arbor.
Distinguished Clinician Awards
The AGA Distinguished Clinician Awards recognize members of the practicing community who, by example, combine the art of medicine with the skills demanded by the scientific body of knowledge in service to their patients.
AGA presents the Distinguished Clinician Award in Private Practice to Kimberly Persley, MD, AGAF. Dr. Persley made a huge impact on patient care in her community as the first IBD-specialty trained private practice gastroenterologist in the Dallas-Fort Worth, Texas, region. She was sought out by gastroenterologists and patients throughout the region for her thorough, kind and holistic care. Dr. Persley is a partner at Texas Digestive Disease Consultants and assistant clinical professor of medicine at the University of Texas Southwestern Medical School, Dallas, Texas.
AGA is honored to present the Distinguished Clinician Award in Clinical Academic Practice, to Gary Lichtenstein, MD, AGAF. Dr. Lichtenstein is a renowned physician, educator, and investigator whose local, regional, and national prominence is remarkable. Patients and physicians throughout the country seek his consultation and advice in IBD. Dr. Lichtenstein is a professor of medicine and director of the IBD Center at the University of Pennsylvania, Philadelphia.
Distinguished Mentor Award
AGA bestows the Distinguished Mentor Award to Juanita Merchant, MD, PhD. This award recognizes an individual who has made a lifelong effort dedicated to the mentoring of trainees in the field of gastroenterology and for achievements as outstanding mentors throughout their careers. Dr. Merchant is an exceptional mentor, providing guidance to multiple learners to jump start, enhance and guide their careers as scientists in gastroenterology. Many of her trainees are faculty in institutions around the world who have also stimulated young learners to pursue careers in science. Dr. Merchant is professor and chief of gastroenterology and hepatology at the University of Arizona, Tucson.
Research Service Award
AGA honors Peter Perrin, PhD, with the Research Service Award, which recognizes individuals whose work has significantly advanced gastroenterological science and research. As a program director at the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, Dr. Perrin has had a huge impact on NIH-funded digestive diseases research. At NIDDK, he has the largest portfolio of grants that have high impact in digestive diseases, in topics including immunology, microbiology, infectious diseases and IBD, barrier and transport functions, and AIDS/HIV.
Outstanding Service Award
AGA honors the Funderburg family with the Outstanding Service Award, which was created in 1972 to honor an individual(s) who has contributed significantly to society’s health and welfare. The family, which includes Rob and Cathy, Alex and Patty, and Hugh and Gail, has significantly contributed to the AGA Research Foundation through their personal philanthropy. Their parents established the AGA – R. Robert and Sally Funderburg Research Award in Gastric Cancer in 1992. In total, the family has given $3 million and with their most recent gift, they have permanently endowed their research award in gastric cancer.
The family encourages collaboration and communication between and among the Funderburg recipients and as a result, AGA established the annual Funderburg Symposium at DDW. This symposium allows leaders in the gastric cancer field, many of whom are past Funderburg recipients, to come together and learn about the latest advances and findings in gastric cancer research.
Young Investigator Awards
The AGA Young Investigator Awards recognize two young investigators, one in basic science and one in clinical science, for outstanding research achievements.
AGA honors Jennifer Lai, MD, MBA, with the Young Investigator Award in Clinical Science. Dr. Lai has pioneered a research program in frailty in hepatology that is changing the way that gastroenterologists and hepatologists manage patients with liver disease. She has carved out a niche at the junction of aging and hepatology research that is particularly timely given the influx of older patients with cirrhosis being seen in clinical practice, as well as the rapid rise in cirrhotic patients with multiple co-morbidities and frailty seeking liver transplantation. Dr. Lai is an associate professor of medicine in residence and director of the Advancing Research in Clinical Hepatology Group in the division of gastroenterology and hepatology, at the University of California, San Francisco.
AGA honors Nobuhiko Kamada, PhD, with the Young Investigator Award in Basic Science. Dr. Kamada is known for his innovation combining fields examining the microbiota and the immune system in IBD, specifically, the interplay between diet, commensal and pathogenic microbes, and the immune system. He has published stellar findings that have been highly cited within short periods of time due to their innovation. Dr. Kamada is an assistant professor in the division of gastroenterology at the University of Michigan Medical School, Ann Arbor.
AGA has announced the 2020 recipients of the annual recognition prizes, given in honor of outstanding contributions and achievements in gastroenterology.
“AGA Recognition Prizes allow members to honor their colleagues and peers for outstanding contributions to the field of gastroenterology,” said Hashem B. El-Serag, MD, MPH, AGAF, president of the AGA Institute. “The 2020 AGA Recognition Prize winners are just a few of the distinguished and talented members who help make AGA such an accomplished organization. We are honored that such esteemed individuals are representatives of AGA.”
The AGA Recognition Prizes will be presented during Digestive Disease Week® 2020, May 1-5, 2020, in Chicago, Illinois.
Julius Friedenwald Medal
AGA bequeaths its highest honor, the Julius Friedenwald Medal, to Gail Hecht, MD, MS, AGAF, for her substantial contributions to the field of gastroenterology and AGA. The Julius Friedenwald Medal, presented annually since 1941, recognizes a physician for lifelong contributions to the field of gastroenterology.
Dr. Hecht is internationally renowned for her pivotal contributions to the understanding of the important diarrheal pathogen, enteropathogenic E. coli. She is also a passionate advocate for the science and practice of gastroenterology, including serving as AGA Institute President. Dr. Hecht’s collegial and generous spirit, her past and continued leadership roles in AGA, her passion for and contributions to science and clinical medicine, and her dedication to both her patients and trainees have strengthened the specialty of gastroenterology, and also inspired and shaped the next generation of investigators and gastroenterologists. Dr. Hecht is currently assistant dean, medical student research and professor of medicine and microbiology/immunology at Loyola University Chicago Stritch School of Medicine, and a staff physician at Hines VA Medical Center, Chicago, Ill.
Distinguished Achievement Award in Basic Science
AGA recognizes R. Balfour Sartor, MD, with the AGA Distinguished Achievement Award in Basic Science, for his major accomplishments in basic science research, which have significantly contributed to the understanding of the pathogenesis of inflammatory bowel diseases (IBD). Dr. Sartor’s seminal observations throughout his career helped launch the area of inquiry that led to the recognition that the microbiome is a key to metabolic disease, IBD, intestinal neoplasia and hepatic disorders. Dr. Sartor is the Margaret W. and Lorimer W. Midgett Distinguished Professor and a professor, departments of medicine, microbiology and immunology, University of North Carolina, Chapel Hill.
William Beaumont Prize
AGA honors two individuals with the William Beaumont Prize in Gastroenterology, which recognizes individuals who have made unique, outstanding contributions of major importance to the field of gastroenterology.
Dennis Ahnen, MD, AGAF, had made many contributions to the field of gastroenterology that have significantly advanced the care of patients through clinical and translational research into the pathobiology of colorectal cancer and its prevention. Dr. Ahnen, has provided exemplary service to AGA. He is director of genetics at Gastroenterology of the Rockies and Professor Emeritus of medicine at the University of Colorado Anschutz Medical Campus School of Medicine, Aurora.
Peter Kahrilas, MD, AGAF, has worked tirelessly and creatively to characterize the function and pathophysiology of the esophagus and has written the esophageal papers upon which a large portion of current research is based. Dr. Kahrilas has also dedicated many years of service to AGA and is currently the Gilbert H. Marquardt Professor of Medicine in the division of gastroenterology at the Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Distinguished Educator Award
AGA honors Robert Fontana, MD, with the Distinguished Educator Award, which recognizes an individual who has made outstanding contributions as an educator in gastroenterology on both local and national levels. Dr. Fontana’s greatest teaching impact has been the establishment of one of the most highly successful transplant hepatology fellowship training programs in the country. He has taught countless medical students, residents and fellows, as well as faculty members via his clear, concise, and well-organized lectures and presentations. Dr. Fontana is a professor of medicine, medical director of liver transplantation, and director of transplant hepatology fellowship ACGME-accredited training program at the University of Michigan, Ann Arbor.
Distinguished Clinician Awards
The AGA Distinguished Clinician Awards recognize members of the practicing community who, by example, combine the art of medicine with the skills demanded by the scientific body of knowledge in service to their patients.
AGA presents the Distinguished Clinician Award in Private Practice to Kimberly Persley, MD, AGAF. Dr. Persley made a huge impact on patient care in her community as the first IBD-specialty trained private practice gastroenterologist in the Dallas-Fort Worth, Texas, region. She was sought out by gastroenterologists and patients throughout the region for her thorough, kind and holistic care. Dr. Persley is a partner at Texas Digestive Disease Consultants and assistant clinical professor of medicine at the University of Texas Southwestern Medical School, Dallas, Texas.
AGA is honored to present the Distinguished Clinician Award in Clinical Academic Practice, to Gary Lichtenstein, MD, AGAF. Dr. Lichtenstein is a renowned physician, educator, and investigator whose local, regional, and national prominence is remarkable. Patients and physicians throughout the country seek his consultation and advice in IBD. Dr. Lichtenstein is a professor of medicine and director of the IBD Center at the University of Pennsylvania, Philadelphia.
Distinguished Mentor Award
AGA bestows the Distinguished Mentor Award to Juanita Merchant, MD, PhD. This award recognizes an individual who has made a lifelong effort dedicated to the mentoring of trainees in the field of gastroenterology and for achievements as outstanding mentors throughout their careers. Dr. Merchant is an exceptional mentor, providing guidance to multiple learners to jump start, enhance and guide their careers as scientists in gastroenterology. Many of her trainees are faculty in institutions around the world who have also stimulated young learners to pursue careers in science. Dr. Merchant is professor and chief of gastroenterology and hepatology at the University of Arizona, Tucson.
Research Service Award
AGA honors Peter Perrin, PhD, with the Research Service Award, which recognizes individuals whose work has significantly advanced gastroenterological science and research. As a program director at the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, Dr. Perrin has had a huge impact on NIH-funded digestive diseases research. At NIDDK, he has the largest portfolio of grants that have high impact in digestive diseases, in topics including immunology, microbiology, infectious diseases and IBD, barrier and transport functions, and AIDS/HIV.
Outstanding Service Award
AGA honors the Funderburg family with the Outstanding Service Award, which was created in 1972 to honor an individual(s) who has contributed significantly to society’s health and welfare. The family, which includes Rob and Cathy, Alex and Patty, and Hugh and Gail, has significantly contributed to the AGA Research Foundation through their personal philanthropy. Their parents established the AGA – R. Robert and Sally Funderburg Research Award in Gastric Cancer in 1992. In total, the family has given $3 million and with their most recent gift, they have permanently endowed their research award in gastric cancer.
The family encourages collaboration and communication between and among the Funderburg recipients and as a result, AGA established the annual Funderburg Symposium at DDW. This symposium allows leaders in the gastric cancer field, many of whom are past Funderburg recipients, to come together and learn about the latest advances and findings in gastric cancer research.
Young Investigator Awards
The AGA Young Investigator Awards recognize two young investigators, one in basic science and one in clinical science, for outstanding research achievements.
AGA honors Jennifer Lai, MD, MBA, with the Young Investigator Award in Clinical Science. Dr. Lai has pioneered a research program in frailty in hepatology that is changing the way that gastroenterologists and hepatologists manage patients with liver disease. She has carved out a niche at the junction of aging and hepatology research that is particularly timely given the influx of older patients with cirrhosis being seen in clinical practice, as well as the rapid rise in cirrhotic patients with multiple co-morbidities and frailty seeking liver transplantation. Dr. Lai is an associate professor of medicine in residence and director of the Advancing Research in Clinical Hepatology Group in the division of gastroenterology and hepatology, at the University of California, San Francisco.
AGA honors Nobuhiko Kamada, PhD, with the Young Investigator Award in Basic Science. Dr. Kamada is known for his innovation combining fields examining the microbiota and the immune system in IBD, specifically, the interplay between diet, commensal and pathogenic microbes, and the immune system. He has published stellar findings that have been highly cited within short periods of time due to their innovation. Dr. Kamada is an assistant professor in the division of gastroenterology at the University of Michigan Medical School, Ann Arbor.
AGA honors today’s luminaries in GI
Celebrate with the AGA Research Foundation. AGA members are pillars of the GI community, dedicated to helping us achieve our goal of a world free of digestive diseases.
To honor the lifelong contributions and achievements of some of our most esteemed members, we are pleased to present the AGA Research Foundation’s newest program, AGA Honors: Celebrating Difference Makers in Our Field.
Our honorees have been chosen for their pivotal role in shaping the future of gastroenterology and hepatology. Honorees span the gamut from mentors and researchers to administrators and clinicians and educators across a myriad of disciplines:
John I. Allen, MD, MBA, AGAF
Rodger A. Liddle, MD
C. Richard Boland, MD, AGAF
David A. Lieberman, MD, AGAF
Martin Brotman, MD, AGAF
Pankaj J. Pasricha, MD
Michael Camilleri, MD, AGAF
Chung Owyang, MD, AGAF
Eugene B. Chang, MD, AGAF
Jean-Pierre Raufman, MD
Sheila Crowe, MD, AGAF
Don C. Rockey, MD, AGAF
Francis M. Giardiello, MD, AGAF
Anil K. Rustgi, MD, AGAF
Fred S. Gorelick, MD
Robert S. Sandler, MD, MPH, AGAF
Gail A. Hecht, MD, AGAF
Michael L. Weinstein, MD
Wayne I. Lencer, MD, AGAF
C. Mel Wilcox, MD
We invite you to learn more about our honorees and to celebrate their contributions to the field by making a donation to the AGA Research Foundation by visiting our website at http://foundation.gastro.org/aga-honors-celebrating/.
Celebrate with the AGA Research Foundation. AGA members are pillars of the GI community, dedicated to helping us achieve our goal of a world free of digestive diseases.
To honor the lifelong contributions and achievements of some of our most esteemed members, we are pleased to present the AGA Research Foundation’s newest program, AGA Honors: Celebrating Difference Makers in Our Field.
Our honorees have been chosen for their pivotal role in shaping the future of gastroenterology and hepatology. Honorees span the gamut from mentors and researchers to administrators and clinicians and educators across a myriad of disciplines:
John I. Allen, MD, MBA, AGAF
Rodger A. Liddle, MD
C. Richard Boland, MD, AGAF
David A. Lieberman, MD, AGAF
Martin Brotman, MD, AGAF
Pankaj J. Pasricha, MD
Michael Camilleri, MD, AGAF
Chung Owyang, MD, AGAF
Eugene B. Chang, MD, AGAF
Jean-Pierre Raufman, MD
Sheila Crowe, MD, AGAF
Don C. Rockey, MD, AGAF
Francis M. Giardiello, MD, AGAF
Anil K. Rustgi, MD, AGAF
Fred S. Gorelick, MD
Robert S. Sandler, MD, MPH, AGAF
Gail A. Hecht, MD, AGAF
Michael L. Weinstein, MD
Wayne I. Lencer, MD, AGAF
C. Mel Wilcox, MD
We invite you to learn more about our honorees and to celebrate their contributions to the field by making a donation to the AGA Research Foundation by visiting our website at http://foundation.gastro.org/aga-honors-celebrating/.
Celebrate with the AGA Research Foundation. AGA members are pillars of the GI community, dedicated to helping us achieve our goal of a world free of digestive diseases.
To honor the lifelong contributions and achievements of some of our most esteemed members, we are pleased to present the AGA Research Foundation’s newest program, AGA Honors: Celebrating Difference Makers in Our Field.
Our honorees have been chosen for their pivotal role in shaping the future of gastroenterology and hepatology. Honorees span the gamut from mentors and researchers to administrators and clinicians and educators across a myriad of disciplines:
John I. Allen, MD, MBA, AGAF
Rodger A. Liddle, MD
C. Richard Boland, MD, AGAF
David A. Lieberman, MD, AGAF
Martin Brotman, MD, AGAF
Pankaj J. Pasricha, MD
Michael Camilleri, MD, AGAF
Chung Owyang, MD, AGAF
Eugene B. Chang, MD, AGAF
Jean-Pierre Raufman, MD
Sheila Crowe, MD, AGAF
Don C. Rockey, MD, AGAF
Francis M. Giardiello, MD, AGAF
Anil K. Rustgi, MD, AGAF
Fred S. Gorelick, MD
Robert S. Sandler, MD, MPH, AGAF
Gail A. Hecht, MD, AGAF
Michael L. Weinstein, MD
Wayne I. Lencer, MD, AGAF
C. Mel Wilcox, MD
We invite you to learn more about our honorees and to celebrate their contributions to the field by making a donation to the AGA Research Foundation by visiting our website at http://foundation.gastro.org/aga-honors-celebrating/.
Now open: registration for DDW® 2020 and the AGA Postgraduate Course
Digestive Disease Week® (DDW) is taking place May 2-5, 2020, at McCormick Place in Chicago, Ill. Featuring clinical care updates – presented nowhere else during DDW – the AGA Postgraduate Course will be held in conjunction with DDW on May 2 and 3. You can register for both together. Visit DDW.org and AGA University, agau.gastro.org, to learn more about each.
Improve patient care
The AGA Postgraduate Course is a comprehensive 1.5-day program highlighting ground-breaking advances in the delivery of high-quality, patient-centered GI care. Attendees will participate in dynamic case-based sessions, learning lunches and panel discussions, and will walk away with best practices for treating a variety of disease states and digestive disorders.
The brightest ideas and breakthroughs in digestive disease
DDW continues to improve and consolidate its reputation as the meeting that brings the brightest ideas and breakthroughs in digestive disease. Prepare to be blown away in the Windy City by all that DDW has to offer:
More than 400 scientific sessions, organized by educational tracks and presented in a wide range of session formats. New sessions include an AGA Clinical Plenary, Topic-Focused Workshops on hypnosis techniques and nutrition, and expanded programming in the DDW Trainee and Early Career Lounge.
Opportunities to connect with over 14,000 attendees from around the world, including top GI experts. New Continuing Conversation blocks, immediately following select invited-speaker sessions, allow you time to network with presenters and fellow attendees.
An Exhibit Hall spotlighting new innovations and technologies that you can implement in your practice.
Digestive Disease Week® (DDW) is taking place May 2-5, 2020, at McCormick Place in Chicago, Ill. Featuring clinical care updates – presented nowhere else during DDW – the AGA Postgraduate Course will be held in conjunction with DDW on May 2 and 3. You can register for both together. Visit DDW.org and AGA University, agau.gastro.org, to learn more about each.
Improve patient care
The AGA Postgraduate Course is a comprehensive 1.5-day program highlighting ground-breaking advances in the delivery of high-quality, patient-centered GI care. Attendees will participate in dynamic case-based sessions, learning lunches and panel discussions, and will walk away with best practices for treating a variety of disease states and digestive disorders.
The brightest ideas and breakthroughs in digestive disease
DDW continues to improve and consolidate its reputation as the meeting that brings the brightest ideas and breakthroughs in digestive disease. Prepare to be blown away in the Windy City by all that DDW has to offer:
More than 400 scientific sessions, organized by educational tracks and presented in a wide range of session formats. New sessions include an AGA Clinical Plenary, Topic-Focused Workshops on hypnosis techniques and nutrition, and expanded programming in the DDW Trainee and Early Career Lounge.
Opportunities to connect with over 14,000 attendees from around the world, including top GI experts. New Continuing Conversation blocks, immediately following select invited-speaker sessions, allow you time to network with presenters and fellow attendees.
An Exhibit Hall spotlighting new innovations and technologies that you can implement in your practice.
Digestive Disease Week® (DDW) is taking place May 2-5, 2020, at McCormick Place in Chicago, Ill. Featuring clinical care updates – presented nowhere else during DDW – the AGA Postgraduate Course will be held in conjunction with DDW on May 2 and 3. You can register for both together. Visit DDW.org and AGA University, agau.gastro.org, to learn more about each.
Improve patient care
The AGA Postgraduate Course is a comprehensive 1.5-day program highlighting ground-breaking advances in the delivery of high-quality, patient-centered GI care. Attendees will participate in dynamic case-based sessions, learning lunches and panel discussions, and will walk away with best practices for treating a variety of disease states and digestive disorders.
The brightest ideas and breakthroughs in digestive disease
DDW continues to improve and consolidate its reputation as the meeting that brings the brightest ideas and breakthroughs in digestive disease. Prepare to be blown away in the Windy City by all that DDW has to offer:
More than 400 scientific sessions, organized by educational tracks and presented in a wide range of session formats. New sessions include an AGA Clinical Plenary, Topic-Focused Workshops on hypnosis techniques and nutrition, and expanded programming in the DDW Trainee and Early Career Lounge.
Opportunities to connect with over 14,000 attendees from around the world, including top GI experts. New Continuing Conversation blocks, immediately following select invited-speaker sessions, allow you time to network with presenters and fellow attendees.
An Exhibit Hall spotlighting new innovations and technologies that you can implement in your practice.